AstraZeneca Prilosec and Nexium: Strategic Challenges in the Launch of a Second-Generation Drug

Subjects Covered
Innovation
International business
Patents
Strategy
Trademarks

by
James G. Conley,
Robert C. Wolcott,
Eric Wong

Source: Kellogg School of Management

20 pages.
Publication Date: Jan 01, 2006. Prod. #: KEL334-PDF-ENG

AstraZeneca, Prilosec, and Nexium: Strategic Challenges in the Launch of a Second-Generation Drug Harvard Case Study Solution and HBR and HBS Case Analysis